Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | MGAM | O43451 | 1/20 | 0.50 |
| ▸ | SI | P14410 | 1/20 | 0.50 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | GSK3A | P49840 | 1/20 | 0.39 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8158517 | 0.81 | GAA (0.50) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL10595181 | 0.79 | GAA (0.48) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL8918311 | 0.79 | GAA (0.48) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL2208577 | 0.77 | CYP1A2 (0.47) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL28373015 | 0.77 | GAA (0.46) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL2836974 | 0.76 | GAA (0.44) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL4440571 | 0.76 | GAA (0.44) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL8975301 | 0.75 | ALDH1A1 (0.38) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL232993 | 0.75 | GAA (0.55) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL21052480 | 0.75 | GAA (0.55) | GAAMGAMSIMGAM2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122090716-A | Nameplate, preparation method thereof and photovoltaic module | — | 2026-05-26 | — | — | CN | disclosed |
| CN-116676025-A | Anti-flooding and anti-aging solid paint | 四川瑞仕嘉科技有限公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-1956998-B | Method for the purification of albumin conjugates | CONJUCHEM INC | 2012-12-12 | — | — | CN | disclosed |
| US-20120022234-A1 | METHOD FOR THE PURIFICATION OF ALBUMIN CONJUGATES | BOUSQUET-GAGNON NATHALIE (CA) | 2012-01-26 | — | — | US | disclosed |
| EP-2230257-A1 | Method for the purification of albumin conjugates | ConjuChem Biotechnologies Inc. (CA) | 2010-09-22 | — | — | EP | disclosed |
| EP-2100904-B1 | Solid phase for use in a method for the purification of albumin conjugates | CONJUCHEM BIOTECHNOLOGIES INC (CA) | 2010-07-07 | — | — | EP | disclosed |
| EP-2100904-A1 | Solid phase for use in a method for the purification of albumin conjugates | ConjuChem Biotechnologies Inc. (CA) | 2009-09-16 | — | — | EP | disclosed |
| EP-1745078-B1 | METHOD FOR THE PURIFICATION OF ALBUMIN CONJUGATES | CONJUCHEM BIOTECHNOLOGIES INC (CA) | 2009-06-17 | — | — | EP | disclosed |
| US-20080146783-A1 | Method for the purification of albumin conjugates | CONJUCHEM BIOTECHNOLOGIES INC. | 2008-06-19 | — | — | US | disclosed |
| US-7307148-B2 | Method for purification of albumin conjugates | CONJUCHEM BIOTECHNOLOGIES INC. (CA) | 2007-12-11 | — | — | US | disclosed |
| EP-1745078-A4 | METHOD FOR THE PURIFICATION OF ALBUMIN CONJUGATES | CONJUCHEM BIOTECHNOLOGIES INC (CA) | 2007-08-01 | — | — | EP | disclosed |
| CN-1956998-A | Method for the purification of albumin conjugates | CONJUCHEM INC (CA) | 2007-05-02 | — | — | CN | disclosed |
| EP-1745078-A1 | METHOD FOR THE PURIFICATION OF ALBUMIN CONJUGATES | ConjuChem Biotechnologies Inc. (CA) | 2007-01-24 | — | — | EP | disclosed |
| CN-1280253-C | Method for preparing 3,3-diethoxy ethyl acrylate | UNIV WUHAN (CN) | 2006-10-18 | — | — | CN | disclosed |
| US-20050267293-A1 | Method for purification of albumin conjugates | CONJUCHEM, INC. (CA) | 2005-12-01 | — | — | US | disclosed |
| WO-2005103087-A1 | METHOD FOR THE PURIFICATION OF ALBUMIN CONJUGATES | CONJUCHEM BIOTECHNOLOGIES INC. (CA) | 2005-11-03 | — | — | WO | disclosed |
| CN-1687010-A | Method for preparing 3,3-diethoxy ethyl acrylate | UNIV WUHAN (CN) | 2005-10-26 | — | — | CN | disclosed |
| WO-2003059356-A2 | NOVEL ANTI-INFECTIVES | SMITHKLINE BEECHAM CORPORATION (US) | 2003-07-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120022234-A1 | METHOD FOR THE PURIFICATION OF ALBUMIN CONJUGATES | ALB, DNPEP, SLC7A1 | GAA 1078/4885MGAM 1450/4885SI 171/4885 |
| US-20050267293-A1 | Method for purification of albumin conjugates | ALB, DNPEP, SLC7A1 | GAA 1163/4885MGAM 1618/4885SI 200/4885 |
| US-20080146783-A1 | Method for the purification of albumin conjugates | ALB, DNPEP, SLC7A1 | GAA 1078/4885MGAM 1450/4885SI 171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.